EPOSS & Sepsis-Q: Design and Description of Projects Focused on Monitoring of Treatment, Morbidity and Mortality of Patients with Severe Sepsis in the Czech Republic
Authors:
Schwarz Daniel 1; Adamus Milan 2; Černý Vladimír 3; Dušek Ladislav 1; Maláska Jan 4; Matějovič Martin 5; Slezák Martin 4; Ševčík Pavel 4,6; Šrámek; Vladimír 7
Authors‘ workplace:
Institut biostatistiky a analýz Masarykovy univerzity
1; Klinika anesteziologie, resuscitace a intenzivní medicíny Lékařské fakulty Univerzity Palackéhoa Fakultní nemocnice Olomouc
2; Klinika anesteziologie, resuscitace a intenzivní medicíny Lékařské fakulty Univerzity Karlovyv Hradci Králové a Fakultní nemocnice Hradec Králové
3; Klinika anesteziologie, resuscitace a intenzivní medicíny Lékařské fakulty Masarykovy univerzitya Fakultní nemocnice Brno
4; I. interní klinika Lékařské fakulty Univerzity Karlovy v Plzni a Fakultní nemocnice Plzeň
5; Anesteziologicko-resuscitační klinika Lékařské fakulty Ostravské univerzity a Fakultní nemocnice Ostrava
6; Anesteziologicko-resuscitační klinika Lékařské fakulty Masarykovy univerzity a Fakultní nemocnice u sv. Anny
7
Published in:
Anest. intenziv. Med., 24, 2013, č. 4, s. 240-249
Category:
Intensive Care Medicine - Original Paper
Overview
Objective:
EPOSS (Data-based Evaluation and Prediction of Outcome in Severe Sepsis) & SEPSIS-Q are research projects aimed at the development of a database for parametric monitoring of patients with severe sepsis and the mapping of sepsis epidemiology in the Czech Republic, as well as on the assessment and improvement of quality of care provided to patients treated for severe sepsis.
Design:
Observational, non-interventional, retrospective study.
Settings:
Selected intensive care units at University and regional hospitals.
Methods:
The article introduces the aims, development of the study protocol and project management, primary and secondary outcomes, database structure and technical solution. The technical solution includes four components: 1. data‑acquisition multicentric system, 2. information website http://eposs.registry.cz, 3. education portal http://www.sepsis-q.cz and 4. an interactive player of educational clinical scenarios of severe sepsis cases.
Conclusion:
The technologies and methods used in the projects help healthcare professionals to assess the quality of health care provided to patients treated for severe sepsis, and promote future physicians’ education using new teaching methods.
Keywords:
severe sepsis, intensive care, research database, non-interventional retrospective data collection, project design, educational clinical scenarios
Sources
1. Angus, D. C. et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Critical Care Medicine, 2001, 29, 7, pp. 1303–1310.
2. Martin, G. S. et al. The Epidemiology of Sepsis in the United States from 1979 through 2000. New England Journal of Medicine, 2013, 348, 16, pp. 1546–1554.
3. Cinel, I., Opal, S. M. Molecular biology of inflammation and sepsis: a primer. Crit. Care Medicine, 2009, 37, 1, pp. 291–304.
4. Doi, K. et al. Animal models of sepsis and sepsis-induced kidney injury. The Journal of Clinical Investigation, 2009, 119, 10, pp. 2868–2878.
5. Namas, Rami et al. Sepsis: Something old, something new, and a systems view. Journal of Critical Care, 2012, 27, 3, p. 314. e311–314.e311. doi: 10.1016/j.jcrc.2011.05.025.
6. Knaus, W. A. The clinical evaluation of new drugs for sepsis: A prospective study design based on survival analysis. JAMA, 1993, 270, 10, pp. 1233–1241.
7. Payen, D. et al. International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: Analysis of efficacy and safety data in a large surgical cohort. Surgery, 2006, 140, 5, pp. 726–739.
8. Fitousis, K. et al. Evaluation of empiric antibiotic use in surgical sepsis. The American Journal of Surgery, 2010, 200, 6, pp. 776–782.
9. Rivers, E. et al. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock. New England Journal of Medicine, 2001, 345, 19, pp. 1368–1377.
10. Dellinger, R. P. et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Critical Care Medicine, 2008, 36, 1.
11. Dellinger, R. P. et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Critical Care Medicine, 2013, 41, 2.
12. Barochia, A. V. et al. Bundled care for septic shock: An analysis of clinical trials. Critical Care Medicine, 2010, 38, 2, pp. 668–678.
13. Lambert, M.-L. et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. The Lancet Infectious Diseases, 2011, 11, 1, pp. 30–38.
14. Westphal, G. A. et al. Reduced mortality after the implementation of a protocol for the early detection of severe sepsis. Journal of Critical Care, 2011, 26, 1, pp. 76–81.
15. Vincent, J. et al. Sepsis in European intensive care units: Results of the SOAP study. Critical Care Medicine, 2006, 34, 2, pp. 344–353.
16. Vincent, J. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European prevalence of infection in intensive care (epic) study. JAMA, 1995, 274, 8, pp. 639–644.
17. Vincent, J. EPIC II: sepsis around the world. Minerva anestesiologica, 2008, 74, 6, pp. 293–296.
18. Hanberger, H. et al. Increased mortality associated with meticillin-resistant Staphylococcus aureus (MRSA) infection in the Intensive Care Unit: results from the EPIC II study. International Journal of Antimicrobial Agents, 2011, 38, 4, pp. 331–335.
19. Karlsson, S. et al. Long-term outcome and quality-adjusted life years after severe sepsis. Critical Care Medicine, 2009, 37, 4, pp. 1268 –1274.
20. Oeyen, S. G. et al. Quality of life after intensive care: a systematic review of the literature. Critical Care Medicine, 2010, 38, 12, pp. 2386–2400.
21. Adrie, C. et al. Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. Journal of Critical Care, 2005, 20, 1, pp. 46–58.
22. Brun-Buisson, C. Épidémiologie des états septiques graves. Dossier thématique : Choc septique, 2006, 35, 3, Part 2, pp. 513–520.
23. Winters, B. D. et al. Long-term mortality and quality of life in sepsis: A systematic review. Critical Care Medicine, 2010, 38, 5, pp. 1276–1283.
24. Černý, V., Novák, I., Šrámek, V. Prevalence těžké sepse v České republice – prospektivní multicentrická jednodenní studie. Anest. Intenziv. Med., 2003, 14, 5, pp. 218–222.
25. Levy, M. M. et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Medicine, 2003, 31, 4, pp. 1250–1256.
26. Maláska, J. et al. Léčba těžké sepse na pracovištích intenzivní péče v České republice – pilotní výsledky projektu EPOSS. Vnitřní lékařství, 2013, akceptováno k publikaci.
Labels
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineArticle was published in
Anaesthesiology and Intensive Care Medicine
2013 Issue 4
Most read in this issue
- Development of the specialty of anaesthesiology and resuscitation at Kladno Hospital in the memoirs of Dr Vladimir Lemon, the first head of the department
- Immune homeostasis (deregulation) in sepsis and septic shock
- Anaesthesia for irreversible electroporation (IRE) prostatectomy: Reversal of neuromuscular blockade with sugammadex vs neostigmin. Retrospective study
- Desflurane facilitates a successful wake-up test in scoliosis surgery in children. Case report